Офтальмохирургия. 2021; : 86-93
Вазопролиферативные опухоли сетчатки. Современный подход к лечению
Городецкая Ю. Б., Яровой А. А., Горшков И. М., Логинов Р. А.
https://doi.org/10.25276/0235-4160-2021-2-86-93Аннотация
Актуальность. Ретинальная вазопролиферативная опухоль является редким приобретенным заболеванием. Точный патогенез развития вазопролиферативной опухоли остается до конца неизвестен, долгое время предполагалось, что ее развитие является реактивным процессом с пролиферацией глиальных клеток и кровеносных сосудов. Несмотря на широкое распространение термина, вазопролиферативную опухоль в полной мере нельзя отнести к истинным опухолям, а также достоверно утверждать то, что она является сосудистой по своему патогенезу. Клиническая картина вазопролиферативной опухоли сетчатки проявляется в виде желтовато-красной, часто рыхлой массы с сосудами нормального или слегка увеличенного калибра, обычно небольшого размера, одиночные и располагаются в нижне-наружном или нижнем отделе глазного дна. Из-за их редкой встречаемости на сегодняшний день отсутствуют единые рекомендации по диагностике и лечению этой патологии. Большинство из доступных методов имеют ограниченную эффективность, вызывая временный регресс процесса, что обусловливает необходимость многократного повторного лечения или комбинирования нескольких методов лечения. В ряде случаев использование нескольких терапевтических опций приводит к осложнениям, которые могут быть вызваны как терапией, так и естественным прогрессированием заболевания, это в совокупности препятствует реконвалесценции и повышению зрительных функций.
Цель. Представить обобщенные данные об эпидемиологии, патогенезе, гистологических особенностях, дифференциальной диагностике и современных подходах к лечению данной патологии.
Материал и методы. В статье использованы литературные мате- риалы отечественных и зарубежных авторов, опубликованные в период с 1982 г. по настоящее время.
Заключение. Требуется дальнейшее исследование механизмов развития вазопролиферативных опухолей и ассоциированных с ними осложнений.
Список литературы
1. Shields JA, Decker WL, Sanborn GE, et al. Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90: 1292–1300. doi: 10.1016/s0161-6420(83)34389-x
2. Henkind P, Morgan G. Peripheral retinal angioma with exudative retinopathy in adults (coat’s lesion). Br J Ophthalmol. 1966;50(1): 2–11. doi: 10.1136/bjo.50.1.2
3. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113: 615–623. doi: 10.1001/archopht.1995.01100050083035
4. Medlock RD, Shields JA, Shields CL, Yarian DL, Beyrer CR. Retinal hemangioma-like lesions in eyes with retinitis pigmentosa. Retina. 1990;10(4): 274–277. doi: 10.1097/00006982-199010000-00009
5. Shields CL, Kaliki S, Al-Dahmash S, et al. Retinal vasoproliferative tumors: comparative clinical features of primary versus secondary tumors in 334 cases. JAMA Ophthalmol. 2013;131(3): 328–334. doi:10.1001/2013.jamaophthalmol.524
6. Barr CC, Rice TA, Michels RG. Angioma-like mass in a patient with retrolental fibroplasia. Am J Ophthalmol. 1980; 89(5): 647–650. doi: 10.1016/0002-9394(80)90281-0
7. Chow CC, Blair MP, Shapiro MJ. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011;129(9): 1234–1235. doi: 10.1001/archophthalmol.2011.265
8. Lafaut BA, Meire F M, Leys AM, Dralands G, De Laey JJ. Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 1999;237(12): 1033–1038. doi: 10.1007/s004170050341
9. Mori K, Ohta K, Murata T. Vasoproliferative tumors of the retina secondary to ocular toxocariasis. Can J Ophthalmol. 2007;42(5): 758–759. doi: 10.3129/i07-137
10. Яровой А.А., Магарамов Д.А., Гаврилова Н.А., Логинов Р.А., Яровая В.А., Коробов Е.Н. Различные подходы к лечению вазопролиферативной опухоли и их результаты. Современные технологии лечения витреоретинальной патологии 2018: Сб. тезисов. М.; 2018: 145–147.
11. Gottlieb F, Fammartino JJ, Stratford TP, Brockhurst RJ. Retinal angiomatous mass: a complication of retinal detachment surgery. Retina. 1984;4: 152–157. doi: 10.1097/00006982-198400430-00004
12. Gray RH, Gregor ZJ. Acquired peripheral retinal telangiectasia after retinal surgery. Retina. 1994;14: 10–13. doi: 10.1097/00006982-199401000-00003
13. Tranos P, Clare G, Sullivan P. Vasoproliferative tumor of the retina after spontaneous reattachment of rhegmatogenous retinal detachment. Retina. 2006;26(4): 475–476. doi: 10.1097/01.iae.0000238541.21262.4b
14. Schwartz PL, Fastenberg DM, Shakin JL. Management of macular puckers associated with retinal angiomas. Ophthalmic Surg. 1990;21: 550–556. doi: 10.1136/bjo.55.7.451
15. Wachtlin J, Heimann H, Jandeck C, et al. Bilateral vasoproliferative retinal tumors with identical localization in a pair of monozygotic twins. Arch Ophthalmol. 2002;120: 860–862.
16. Irvine F, O’Donnell N, Kemp E, Lee WR. Retinal vasoproliferative tumors: surgical management and histological findings. Arch Ophthalmol. 2000;118(4): 563–569. doi: 10.1001/archopht.118.4.563
17. Smeets MH, Mooy CM, Baarsma GS, Mertens DE, Van Meurs JC. Histopathology of a vasoproliferative tumor of the ocular fundus. Retina. 1998;18(5): 470–472. doi: 10.1097/00006982-199805000-00016
18. Poole Perry LJ, Jakobiec FA, Zakha FR, et al. Reactive retinal astrocytic tumors (so– called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol. 2013;155: 593–608. doi: 10.1016/j.ajo.2013.03.016
19. Manjandavida FP, Shields CL, Kaliki S, et al. Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases. Retina. 2014;34: 1644–1650.doi: 10.1097/iae.0000000000000137
20. Rennie I. G. Retinal vasoproliferative tumours. Eye. 2010; 24: 468–471. doi: 10.1038/eye.2009.305
21. Enzinger FM, Weiss SW. Benign tumors and tumorlike lesions of blood vessels. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St. Louis: C.V. Mosby; 1995: 581–593.
22. Montgomery EA, Fetsch JF. Tumors and tumefactions of peripheral vessels. In: Stehbens WE, Lie Jt. Vascular pathology. London: Chapman & Hall Medical; 1995: 739–761.
23. Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000; 84(10): 1162–1169. doi: 10.1136/bjo.84.10.1162
24. Garcia-Arumi J, Diestefano LN, Fonollosa A, Quijano C, Corcostegui B. Management of visionthreatening complications of vasoproliferative tumors of the retina. Ophthalmic Res. 2015;54(1): 34–40. doi: 10.1159/000430955
25. Laatikainen L, Immonen I, Summanen P. Peripheral retinal angioma like lesion and macular pucker. Am J Ophthalmol. 1989;108: 563–566. doi: 10.1016/0002-9394(89)90434-0
26. Machemer R. Peripheral retinal angioma like lesion and macular pucker. Am J Ophthalmol. 1988;105: 170–181. doi: 10.1016/s0002-9394(14)76006-4
27. Makdoumi K, Crafoord S. Vasoproliferative retinal tumours in a Swedish population. Acta Ophthalmol. 2011;89(1): 914. doi: 10.1111/j.1755-3768.2009.01662.x
28. Piñeiro-Ces A, Blanco-Teijeiro MJ, Mera-Yáñez MP, et al. Ultrasound diagnosis in vasoproliferative tumours of the ocular fundus. Arch Soc Esp Oftalmol. 2011;86: 247–53. doi.org/10.1016/j.oftale.2011.04.003
29. Tsui I, Jain A, Shah S, Schwartz SD, McCannel T. Ultrawidefield imaging of peripheral exudative hemorrhagic chorioretinopathy. Semin Ophthalmol. 2009;24(1): 25–28. doi: 10.1080/08820530802520178
30. Bechrakis NE, Foerster MH, Bornfeld N. Biopsy in indeterminate intraocular tumors. Ophthalmology. 2002;109(2): 235–242. doi: 10.1016/s0161-6420(01)00931-9
31. Кравченко И.З., Худяков А.Ю., Сорокин Е.Л. Пятилетний опыт и эффективность лечения вазопролиферативных опухолей сетчатки. Современные технологии лечения витреоретинальной патологии – 2017: Сб. тезисов. М.; 2017: 145–147.
32. Schlesinger T, Appukuttan B, Hwang T, et al. Internal enbloc resection and genetic analysis of retinal capillary hemangioblastoma. Arch Ophthalmol. 2007;125(9): 1189–1193. doi: 10.1001/archopht.125.9.1189
33. Hussain RN, Jmor F, Damato B, et al. Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology. 2015;122: 2361–2363. doi: 10.1097/01.iae.0000238554.61165.fd
34. Marback EF, Guerra RL, de Oliveira Maia O. Jr, et al. Retinal vasoproliferative tumor. Arq Bras Oftalmol. 2013; 76: 200–203. doi: 10.1590/s0004-27492013000300016
35. Rogers C, Damato B, Kumar I, Heimann H. Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours. Eye. 2014;28: 968–973. doi: 10.1038/eye.2014.113
36. Saldanha M.J., Edrich C. Treatment of vasoproliferative tumors with photodynamic therapy. Ophthalmic Surg Lasers Imaging 2008;39:143–145. doi: 10.3928/15428877-20080301-13
37. Yeh S, Wilson DJ. Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. Arch Ophthalmol. 2010;128(9): 1196–1199. doi: 10.1001/ archophthalmol.2010.194
38. Casswell AG, Clifford-Jones R, Grewa IK, Gregor ZJ. Isolated retinal telangiectasis masses. Trans Ophthalmol Soc UK. 1986; 105(1): 94–99.
39. Campochiaro PA, Conway BP. Hemangiomalike masses of the retina. Arch Ophthalmol. 1988;106(10): 1409–1413. doi: 10.1001/archopht.1988.01060140573025
40. Damato B. Vasoproliferative retinal tumour. Br J Ophthalmol. 2006;90(4): 399–400. Comment on Br J Ophthalmol. 2006;90(4):447-50. doi: 10.1136/bjo.2005.086066
41. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46: 1440-1444. doi: 10.1167/iovs.04-0905
42. Krivosic V, Massin P, Desjardins L, Le Hoang P, Tadayoni R, Gaudric A. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation. Am J Ophthalmol. 2014;158(1): 154–161. doi: 10.1016/j.ajo.2014.03.005
43. Сдобникова С.В., Сургуч В.К., Большунов А.В., Сосновский В.В., Троицкая Н.А. Комбинированная транссклеральная и транспупиллярная термотерапия при больших вазопролиферативных опухолях сетчатки. Вестник офтальмологии. 2014;1: 85–90.
44. Юнина М.А., Педанова Е.К., Крыль Л.А. Первые результаты фокальной лазеркоагуляции реактивной ретинальной астроцитарной опухоли. Современные технологии в офтальмологии. 2015.3: 194–195.
45. Boixadera A, Garcia Arumi J, Martinez Castillo V, Encinas JL, Elizalde J, Blanco Mateos G, et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009;116(1): 1005.e1. doi: 10.1016/j.ophtha.2008.08.029
46. Heimann H, Bornfeld N, Vij O, Coupland SE, Bechrakis NE, Kellner U, Foerster MH. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84: 1162–1169. doi: 10.1136/bjo.84.10.1162
47. Laqua H, Wessing A. Peripheral retinal telangiectasis in adults simulating a vascular tumor or melanoma. Ophthalmology. 1983;90: 1284–1291. doi: 10.1016/s0161-6420(83)34390-6
48. Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Tumor vasoproliferativo associado a tuberculose ocular presumida: relato de caso. Arq Bras Oftalmol. 2007;70(3): 527–531. [Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Vasoproliferative tumor associated with presumed ocular tuberculosis: case report. Arq Bras Oftalmol. 2007;70(3): 527–531. (in Portug.)] doi: 10.1590/s0004-27492007000300025
49. Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006;90(4): 447–450. doi: 10.1136/bjo.2005.081422
50. Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica. 2011;226(Suppl 1): 42–45. doi: 10.1159/000328209
51. Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008;126(9): 1245–1251. doi: 10.1001/archopht.126.9.1245
52. Oberstein SY, Byun J, Herrera D, et al. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis. 2011; 17:1794–1805.
53. Shankar P, Bradshaw SE, Ang A, Rennie IG, Snead DR, Snead MP. Vascularised epiretinal membrane associated with vasoproliferative tumour. Eye (Lond). 2007;21(7):1003-4. doi: 10.1038/sj.eye.6702800
54. Snead DR, James S, Snead MP. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye (Lond). 2008;22: 550–556. doi: 10.1038/eye.2008.36
55. Hiscott P, Mudhar H. Is vasoproliferative tumor (reactive retinal glioangiosis) part of the spectrum of proliferative vitreoretinopathy? Eye (Lond). 2009;23: 1851–1858. doi: 10.1038/eye.2008.351
56. Zhao F, Gandorfer A, Haritoglou C, et al. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flatmounted internal limiting membrane specimens. Retina. 2013;33: 77e88. doi: 10.1097/iae.0b013e3182602087
57. Huang YM, Chen SJ. Clinical characters and treatments of retinal vasoproliferative tumors. Taiwan J Ophthalmol. 2016;6: 85–88. doi: 10.1016/j.tjo.2016.04.003
58. Castro-Navarro V, Saktanasate J, Say EA, Chiang A, Shields CL. Role of pars plana vitrectomy and membrane peel in vitreomacular traction associated with retinal vasoproliferative tumors. Oman J Ophthalmol. 2016;9(3): 167–169. doi: 10.4103/0974-620x.192280
59. Линник Л.Ф., Легошин В.А., Шигина Н.А. Экспериментальное обоснование микрохирургического интраокулярного удаления опухолей сосудистой оболочки в сочетании с лазеркоагуляцией. В кн.: Лазерные методы лечения и ангио- графического исследования в офтальмологии. Сб. научн. тр. М.; 1983: 78–81.
60. Linnik LF, Legoshin VA, Shigina NA. Eksperimental’noye obosnovaniye mikrokhirurgicheskogo intraokulyarnogo udaleniya opukholey sosudistoy obolochki v sochetanii s lazerkoagulyatsiyey. In: Lazernie metody lecheniya i angiografichesskogo issledovaniya v ophtal’mologii. M.; 1983: 78–81 (In Russ.)
61. Damato B, Groenewald C, McGalliard J, Wong D. Endoresection of choroidal melanoma. Br J Ophthalmol. 1998;82(3): 213–218. doi: 10.1136/bjo.82.3.213
62. Karkhaneh R, Chams H, Amoli FA, et al. Longterm surgical outcome of posterior choroidal melanoma treated by endoresection. Retina. 2007;27(7): 908–914. doi: 10.1097/iae.0b013e31802fa2db
63. Kreusel KM, Bechrakis NE, Neumann HP, Foerster MH. Pars plana vitrectomy for juxtapapillary capillary retinal angioma. Am J Ophthalmol. 2006;141(3): 587–589. doi: 10.1016/j.ajo.2005.10.014
64. Gibran SK. Transvitreal endoresection for vasoproliferative retinal tumours. Clin Experiment Ophthalmol. 2008;36(8): 7126. doi: 10.1111/j.1442-9071.2008.01880.x
65. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina. 2013;33: 1959–1967. doi: 10.1097/iae.0b013e3182923490
66. Japiassu RM, Brasil OFM, Cunha AL, de Souza EC. Regression of vasoproliferative tumor with systemic infliximab. Ophthalmic Surg Lasers Imaging. 2008; 39: 348–349. doi: 10.3928/15428877-20080701-09
Fyodorov Journal of Ophthalmic Surgery. 2021; : 86-93
Vasoproliferative retinal tumors. Current approach to treatment Relevance. Vasoproliferative retinal tumor is a rare acquired disease.
Gorodetskaya Yu. B., Yarovoy A. A., Gorshkov I. M., Loginov R. A.
https://doi.org/10.25276/0235-4160-2021-2-86-93Abstract
The exact pathogenesis of vasoproliferative tumors remains completely unknown, and it has long been assumed that their development is a reactive process with the proliferation of glial cells and blood vessels. Despite the widespread use of this term, vasoproliferative tumor cannot be fully attributed to true tumors and it cannot be reliably established that it is vascular in its pathogenesis. The clinical signs of vasoproliferative retinal tumor manifests itself as a yellowish-red, often loose mass with vessels of normal or slightly enlarged caliber, usually small, single and located in the lower-outer or lower part of the fundus. Due to their rarity, there are currently no uniform recommendations for the diagnosis and treatment of this pathology. Most of the available methods have limited effectiveness, causing a temporary regression of the process, which makes it necessary to repeatedly re-treat or combine several treatments. In some cases, the use of several therapeutic options leads to complications that can be caused by both therapy and the natural progression of the disease, which together prevents reconvalescence and improvement of visual func tions.
Purpose. This article presents for the first time a detailed review of the literature, including generalized data on the epidemiology, pathogenesis, histological features, differential diagnosis and modern approaches to the treatment of this pathology.
Material and methods. The article uses literary materials of domestic and foreign authors published in the period from 1982 to the present.
Conclusion. It is necessary to further study the mechanisms of development of vasoproliferative tumors and related complications.
References
1. Shields JA, Decker WL, Sanborn GE, et al. Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90: 1292–1300. doi: 10.1016/s0161-6420(83)34389-x
2. Henkind P, Morgan G. Peripheral retinal angioma with exudative retinopathy in adults (coat’s lesion). Br J Ophthalmol. 1966;50(1): 2–11. doi: 10.1136/bjo.50.1.2
3. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113: 615–623. doi: 10.1001/archopht.1995.01100050083035
4. Medlock RD, Shields JA, Shields CL, Yarian DL, Beyrer CR. Retinal hemangioma-like lesions in eyes with retinitis pigmentosa. Retina. 1990;10(4): 274–277. doi: 10.1097/00006982-199010000-00009
5. Shields CL, Kaliki S, Al-Dahmash S, et al. Retinal vasoproliferative tumors: comparative clinical features of primary versus secondary tumors in 334 cases. JAMA Ophthalmol. 2013;131(3): 328–334. doi:10.1001/2013.jamaophthalmol.524
6. Barr CC, Rice TA, Michels RG. Angioma-like mass in a patient with retrolental fibroplasia. Am J Ophthalmol. 1980; 89(5): 647–650. doi: 10.1016/0002-9394(80)90281-0
7. Chow CC, Blair MP, Shapiro MJ. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011;129(9): 1234–1235. doi: 10.1001/archophthalmol.2011.265
8. Lafaut BA, Meire F M, Leys AM, Dralands G, De Laey JJ. Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 1999;237(12): 1033–1038. doi: 10.1007/s004170050341
9. Mori K, Ohta K, Murata T. Vasoproliferative tumors of the retina secondary to ocular toxocariasis. Can J Ophthalmol. 2007;42(5): 758–759. doi: 10.3129/i07-137
10. Yarovoi A.A., Magaramov D.A., Gavrilova N.A., Loginov R.A., Yarovaya V.A., Korobov E.N. Razlichnye podkhody k lecheniyu vazoproliferativnoi opukholi i ikh rezul'taty. Sovremennye tekhnologii lecheniya vitreoretinal'noi patologii 2018: Sb. tezisov. M.; 2018: 145–147.
11. Gottlieb F, Fammartino JJ, Stratford TP, Brockhurst RJ. Retinal angiomatous mass: a complication of retinal detachment surgery. Retina. 1984;4: 152–157. doi: 10.1097/00006982-198400430-00004
12. Gray RH, Gregor ZJ. Acquired peripheral retinal telangiectasia after retinal surgery. Retina. 1994;14: 10–13. doi: 10.1097/00006982-199401000-00003
13. Tranos P, Clare G, Sullivan P. Vasoproliferative tumor of the retina after spontaneous reattachment of rhegmatogenous retinal detachment. Retina. 2006;26(4): 475–476. doi: 10.1097/01.iae.0000238541.21262.4b
14. Schwartz PL, Fastenberg DM, Shakin JL. Management of macular puckers associated with retinal angiomas. Ophthalmic Surg. 1990;21: 550–556. doi: 10.1136/bjo.55.7.451
15. Wachtlin J, Heimann H, Jandeck C, et al. Bilateral vasoproliferative retinal tumors with identical localization in a pair of monozygotic twins. Arch Ophthalmol. 2002;120: 860–862.
16. Irvine F, O’Donnell N, Kemp E, Lee WR. Retinal vasoproliferative tumors: surgical management and histological findings. Arch Ophthalmol. 2000;118(4): 563–569. doi: 10.1001/archopht.118.4.563
17. Smeets MH, Mooy CM, Baarsma GS, Mertens DE, Van Meurs JC. Histopathology of a vasoproliferative tumor of the ocular fundus. Retina. 1998;18(5): 470–472. doi: 10.1097/00006982-199805000-00016
18. Poole Perry LJ, Jakobiec FA, Zakha FR, et al. Reactive retinal astrocytic tumors (so– called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol. 2013;155: 593–608. doi: 10.1016/j.ajo.2013.03.016
19. Manjandavida FP, Shields CL, Kaliki S, et al. Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases. Retina. 2014;34: 1644–1650.doi: 10.1097/iae.0000000000000137
20. Rennie I. G. Retinal vasoproliferative tumours. Eye. 2010; 24: 468–471. doi: 10.1038/eye.2009.305
21. Enzinger FM, Weiss SW. Benign tumors and tumorlike lesions of blood vessels. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St. Louis: C.V. Mosby; 1995: 581–593.
22. Montgomery EA, Fetsch JF. Tumors and tumefactions of peripheral vessels. In: Stehbens WE, Lie Jt. Vascular pathology. London: Chapman & Hall Medical; 1995: 739–761.
23. Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000; 84(10): 1162–1169. doi: 10.1136/bjo.84.10.1162
24. Garcia-Arumi J, Diestefano LN, Fonollosa A, Quijano C, Corcostegui B. Management of visionthreatening complications of vasoproliferative tumors of the retina. Ophthalmic Res. 2015;54(1): 34–40. doi: 10.1159/000430955
25. Laatikainen L, Immonen I, Summanen P. Peripheral retinal angioma like lesion and macular pucker. Am J Ophthalmol. 1989;108: 563–566. doi: 10.1016/0002-9394(89)90434-0
26. Machemer R. Peripheral retinal angioma like lesion and macular pucker. Am J Ophthalmol. 1988;105: 170–181. doi: 10.1016/s0002-9394(14)76006-4
27. Makdoumi K, Crafoord S. Vasoproliferative retinal tumours in a Swedish population. Acta Ophthalmol. 2011;89(1): 914. doi: 10.1111/j.1755-3768.2009.01662.x
28. Piñeiro-Ces A, Blanco-Teijeiro MJ, Mera-Yáñez MP, et al. Ultrasound diagnosis in vasoproliferative tumours of the ocular fundus. Arch Soc Esp Oftalmol. 2011;86: 247–53. doi.org/10.1016/j.oftale.2011.04.003
29. Tsui I, Jain A, Shah S, Schwartz SD, McCannel T. Ultrawidefield imaging of peripheral exudative hemorrhagic chorioretinopathy. Semin Ophthalmol. 2009;24(1): 25–28. doi: 10.1080/08820530802520178
30. Bechrakis NE, Foerster MH, Bornfeld N. Biopsy in indeterminate intraocular tumors. Ophthalmology. 2002;109(2): 235–242. doi: 10.1016/s0161-6420(01)00931-9
31. Kravchenko I.Z., Khudyakov A.Yu., Sorokin E.L. Pyatiletnii opyt i effektivnost' lecheniya vazoproliferativnykh opukholei setchatki. Sovremennye tekhnologii lecheniya vitreoretinal'noi patologii – 2017: Sb. tezisov. M.; 2017: 145–147.
32. Schlesinger T, Appukuttan B, Hwang T, et al. Internal enbloc resection and genetic analysis of retinal capillary hemangioblastoma. Arch Ophthalmol. 2007;125(9): 1189–1193. doi: 10.1001/archopht.125.9.1189
33. Hussain RN, Jmor F, Damato B, et al. Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology. 2015;122: 2361–2363. doi: 10.1097/01.iae.0000238554.61165.fd
34. Marback EF, Guerra RL, de Oliveira Maia O. Jr, et al. Retinal vasoproliferative tumor. Arq Bras Oftalmol. 2013; 76: 200–203. doi: 10.1590/s0004-27492013000300016
35. Rogers C, Damato B, Kumar I, Heimann H. Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours. Eye. 2014;28: 968–973. doi: 10.1038/eye.2014.113
36. Saldanha M.J., Edrich C. Treatment of vasoproliferative tumors with photodynamic therapy. Ophthalmic Surg Lasers Imaging 2008;39:143–145. doi: 10.3928/15428877-20080301-13
37. Yeh S, Wilson DJ. Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. Arch Ophthalmol. 2010;128(9): 1196–1199. doi: 10.1001/ archophthalmol.2010.194
38. Casswell AG, Clifford-Jones R, Grewa IK, Gregor ZJ. Isolated retinal telangiectasis masses. Trans Ophthalmol Soc UK. 1986; 105(1): 94–99.
39. Campochiaro PA, Conway BP. Hemangiomalike masses of the retina. Arch Ophthalmol. 1988;106(10): 1409–1413. doi: 10.1001/archopht.1988.01060140573025
40. Damato B. Vasoproliferative retinal tumour. Br J Ophthalmol. 2006;90(4): 399–400. Comment on Br J Ophthalmol. 2006;90(4):447-50. doi: 10.1136/bjo.2005.086066
41. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46: 1440-1444. doi: 10.1167/iovs.04-0905
42. Krivosic V, Massin P, Desjardins L, Le Hoang P, Tadayoni R, Gaudric A. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation. Am J Ophthalmol. 2014;158(1): 154–161. doi: 10.1016/j.ajo.2014.03.005
43. Sdobnikova S.V., Surguch V.K., Bol'shunov A.V., Sosnovskii V.V., Troitskaya N.A. Kombinirovannaya transskleral'naya i transpupillyarnaya termoterapiya pri bol'shikh vazoproliferativnykh opukholyakh setchatki. Vestnik oftal'mologii. 2014;1: 85–90.
44. Yunina M.A., Pedanova E.K., Kryl' L.A. Pervye rezul'taty fokal'noi lazerkoagulyatsii reaktivnoi retinal'noi astrotsitarnoi opukholi. Sovremennye tekhnologii v oftal'mologii. 2015.3: 194–195.
45. Boixadera A, Garcia Arumi J, Martinez Castillo V, Encinas JL, Elizalde J, Blanco Mateos G, et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009;116(1): 1005.e1. doi: 10.1016/j.ophtha.2008.08.029
46. Heimann H, Bornfeld N, Vij O, Coupland SE, Bechrakis NE, Kellner U, Foerster MH. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84: 1162–1169. doi: 10.1136/bjo.84.10.1162
47. Laqua H, Wessing A. Peripheral retinal telangiectasis in adults simulating a vascular tumor or melanoma. Ophthalmology. 1983;90: 1284–1291. doi: 10.1016/s0161-6420(83)34390-6
48. Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Tumor vasoproliferativo associado a tuberculose ocular presumida: relato de caso. Arq Bras Oftalmol. 2007;70(3): 527–531. [Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Vasoproliferative tumor associated with presumed ocular tuberculosis: case report. Arq Bras Oftalmol. 2007;70(3): 527–531. (in Portug.)] doi: 10.1590/s0004-27492007000300025
49. Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006;90(4): 447–450. doi: 10.1136/bjo.2005.081422
50. Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica. 2011;226(Suppl 1): 42–45. doi: 10.1159/000328209
51. Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008;126(9): 1245–1251. doi: 10.1001/archopht.126.9.1245
52. Oberstein SY, Byun J, Herrera D, et al. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis. 2011; 17:1794–1805.
53. Shankar P, Bradshaw SE, Ang A, Rennie IG, Snead DR, Snead MP. Vascularised epiretinal membrane associated with vasoproliferative tumour. Eye (Lond). 2007;21(7):1003-4. doi: 10.1038/sj.eye.6702800
54. Snead DR, James S, Snead MP. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye (Lond). 2008;22: 550–556. doi: 10.1038/eye.2008.36
55. Hiscott P, Mudhar H. Is vasoproliferative tumor (reactive retinal glioangiosis) part of the spectrum of proliferative vitreoretinopathy? Eye (Lond). 2009;23: 1851–1858. doi: 10.1038/eye.2008.351
56. Zhao F, Gandorfer A, Haritoglou C, et al. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flatmounted internal limiting membrane specimens. Retina. 2013;33: 77e88. doi: 10.1097/iae.0b013e3182602087
57. Huang YM, Chen SJ. Clinical characters and treatments of retinal vasoproliferative tumors. Taiwan J Ophthalmol. 2016;6: 85–88. doi: 10.1016/j.tjo.2016.04.003
58. Castro-Navarro V, Saktanasate J, Say EA, Chiang A, Shields CL. Role of pars plana vitrectomy and membrane peel in vitreomacular traction associated with retinal vasoproliferative tumors. Oman J Ophthalmol. 2016;9(3): 167–169. doi: 10.4103/0974-620x.192280
59. Linnik L.F., Legoshin V.A., Shigina N.A. Eksperimental'noe obosnovanie mikrokhirurgicheskogo intraokulyarnogo udaleniya opukholei sosudistoi obolochki v sochetanii s lazerkoagulyatsiei. V kn.: Lazernye metody lecheniya i angio- graficheskogo issledovaniya v oftal'mologii. Sb. nauchn. tr. M.; 1983: 78–81.
60. Linnik LF, Legoshin VA, Shigina NA. Eksperimental’noye obosnovaniye mikrokhirurgicheskogo intraokulyarnogo udaleniya opukholey sosudistoy obolochki v sochetanii s lazerkoagulyatsiyey. In: Lazernie metody lecheniya i angiografichesskogo issledovaniya v ophtal’mologii. M.; 1983: 78–81 (In Russ.)
61. Damato B, Groenewald C, McGalliard J, Wong D. Endoresection of choroidal melanoma. Br J Ophthalmol. 1998;82(3): 213–218. doi: 10.1136/bjo.82.3.213
62. Karkhaneh R, Chams H, Amoli FA, et al. Longterm surgical outcome of posterior choroidal melanoma treated by endoresection. Retina. 2007;27(7): 908–914. doi: 10.1097/iae.0b013e31802fa2db
63. Kreusel KM, Bechrakis NE, Neumann HP, Foerster MH. Pars plana vitrectomy for juxtapapillary capillary retinal angioma. Am J Ophthalmol. 2006;141(3): 587–589. doi: 10.1016/j.ajo.2005.10.014
64. Gibran SK. Transvitreal endoresection for vasoproliferative retinal tumours. Clin Experiment Ophthalmol. 2008;36(8): 7126. doi: 10.1111/j.1442-9071.2008.01880.x
65. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina. 2013;33: 1959–1967. doi: 10.1097/iae.0b013e3182923490
66. Japiassu RM, Brasil OFM, Cunha AL, de Souza EC. Regression of vasoproliferative tumor with systemic infliximab. Ophthalmic Surg Lasers Imaging. 2008; 39: 348–349. doi: 10.3928/15428877-20080701-09
События
-
К платформе Elpub присоединился журнал «The BRICS Health Journal» >>>
10 июн 2025 | 12:52 -
Журнал «Неотложная кардиология и кардиоваскулярные риски» присоединился к Elpub >>>
6 июн 2025 | 09:45 -
К платформе Elpub присоединился «Медицинский журнал» >>>
5 июн 2025 | 09:41 -
НЭИКОН принял участие в конференции НИИ Организации здравоохранения и медицинского менеджмента >>>
30 мая 2025 | 10:32 -
Журнал «Творчество и современность» присоединился к Elpub! >>>
27 мая 2025 | 12:38